help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heikkilä, M.
Right arrow Articles by Vainio, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heikkilä, M.
Right arrow Articles by Vainio, S.
Endocrinology Vol. 143, No. 11 4358-4365
Copyright © 2002 by The Endocrine Society


ARTICLE

Wnt-4 Deficiency Alters Mouse Adrenal Cortex Function, Reducing Aldosterone Production

Minna Heikkilä1, Hellevi Peltoketo1, Juhani Leppäluoto, Mika Ilves, Olli Vuolteenaho and Seppo Vainio

Biocenter Oulu and Department of Biochemistry (M.H., H.P.), Biocenter Oulu and Department of Physiology (J.L., M.I., O.V.), Biocenter Oulu and Department of Biochemistry (S.V.), Faculties of Science and Medicine, University of Oulu, FIN-90014 University of Oulu, Finland

Address all correspondence and requests for reprints to: Prof. Seppo Vainio, Biocenter Oulu and Department of Biochemistry, Faculties of Science and Medicine, P.O. Box 3000, University of Oulu, FIN-90014 University of Oulu, Finland. E-mail: seppo.vainio{at}oulu.fi.


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Wnt-4 is a signaling factor with multiple roles in organogenesis, a deficiency that leads to abnormal development of the kidney, pituitary gland, female reproductive system, and mammary gland. Wnt-4 is expressed in the cortical region of the developing adrenal gland from embryonic d 11.5 onward, especially in the outermost part. Expression of Cyp11B2 and preadipocyte factor 1 is lowered in the glands of Wnt-4 mutant animals, resulting in significantly reduced aldosterone production in the newborn mutants, suggesting that Wnt-4 may be needed for proper formation of the zona glomerulosa. On the other hand, both proopiomelanocortin-derived peptide ß-endorphin and corticosterone concentration levels are elevated in Wnt-deficient mice, and the expression of Cyp17 is altered in Wnt-4 mutant females, so that it mimics the pattern specific for males. Finally, some cells that are positive for Cyp21, which is normally expressed only in the adrenal gland, are found in the gonads of Wnt-4-deficient embryos, indicating that Wnt-4 may play a role in cell migration or in the sorting of adrenal and gonadal cells during early development. In summary, these results point to a role for Wnt-4 in adrenal gland development and function.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
THE ADRENAL GLAND is composed of two tissues of different embryological origin: a mesodermal cortex and a neural crest ectoderm-derived medulla (1). The cortex forms the major part of the gland and is divided into three layers in mammals: the zona glomerulosa immediately beneath the capsule, followed by the zona fasciculata and the innermost zona reticularis. The last-mentioned zone is replaced in mice by the X-zone, which develops prenatally and begins to degenerate at pubertal maturity in males and during the early phase of the first pregnancy in females (2).

As the cortex maintains water, electrolyte, and carbohydrate balances, its proper functioning is vital. Dozens of steroidal compounds, collectively referred to as corticosteroids, have been isolated from the cortex, but only a few of them have biological activity. The production of these corticosteroids, which can be divided into mineralocorticoids, glucocorticoids, and androgens, is regulated by the renin-angiotensin system and hypothalamic-pituitary-adrenal axis. The main mineralocorticoid, aldosterone, is synthesized in the zona glomerulosa, whereas the zona fasciculata and zona reticularis produce glucocorticoids such as corticosterone and cortisol. The adrenal medulla consists of ganglion and chromaffin cells, the latter producing norepinephrine, epinephrine, chromogranins, and neuropeptides, which are components of the autonomic nervous system (1, 3). Despite the different characteristics of the cortex and medulla, the adrenocortical and chromaffin cells of the medulla are intermingled and interact with each other (3).

The murine adrenal gland starts its development on embryonic day (E) 11, when the anlage of the adrenal cortex is formed (4). At the same time the first medullary cells also appear: two chains of sympathoblasts located on either side of the aorta. The cortex forms by budding from the coelomic epithelium between the mesogastrium and the urogenital fold, and the anlage is further pushed out between the mesonephros and the aorta. On E12 the cortical cells are found close to the adrenal medulla sympathoblasts, and by E14 the medullary cells are located within the adrenal gland. The capsule surrounding the adrenal gland and the cortical capillaries are also formed on E14, and both the cortex and the capsule have completed their development by E15. The murine adrenal gland is fully functional at birth (1). Key factors in adrenal cortex development are steroidogenic factor-1 (Sf1) and Wilm’s tumor-1, a deficiency in which will cause a total lack of the adrenal gland (5, 6, 7). Development of the cortex is also connected with the functioning of the hypothalamus-pituitary-adrenal axis, in that a lack of CRH and its receptors will cause severe alterations in the structure of the adrenal cortex, and steroidogenic acute regulatory protein knockout mice show abnormal cellular architecture and abundant lipoid deposits in the cortex, for example (8, 9).

Wnt signaling is involved in the development of several organs. Wnts are molecules regulating growth and differentiation, and they mediate their signal via at least three pathways; the ß-catenin (10) and the planar cell polarity (11, 12) pathways, which are dependent on frizzled receptor and disheveled, and the disheveled-independent, protein kinase C pathway (13). Wnt-4 is essential for the proper development and functioning of the kidney (14), pituitary gland (15), Mullerian duct, and ovary (16). Wnt-4-deficient mice die within 24 h of birth, probably because of kidney dysfunction, as the kidney tubules fail to form without the Wnt-4 gene (14). The pituitary gland of the Wnt-4 mutant mouse is also poorly developed and is practically devoid of all cell types other than corticotropes, the cells producing proopiomelanocortin-derived hormones, such as ACTH, MSH, ß-endorphin, and ß-lipotropin (15). Both male and female Wnt-4-deficient mice lack any Mullerian duct, and the females show partial sex reversal, with oocyte degeneration (16). Finally, Wnt-4 is involved in progesterone-dependent mammary gland branching (17). We report here on the expression of Wnt-4 in the adrenal gland and show that lack of the gene leads to altered functioning of the gland as well.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The Wnt-4-deficient mouse line and genotyping of the animals
The generation of the Wnt-4-deficient mouse line was originally described by Stark et al. (14). The mice used here were of a mixed 129SV and CD-1 background, the line showing a similar phenotype to the original Wnt-4-deficient line 129SV (data not shown). The Wnt-4+/- and Wnt-4+/+ mice were considered equal here and are referred to below as being of the wild-type (wt), because no obvious phenotype has been observed in the heterozygotes. The animals originated from crossings of Wnt-4 heterozygous mice, and wt embryonic and newborn littermates were used as controls for the Wnt-4 mutants. The experiments described here were approved by the local committee on animal care. The genotypes of the embryos younger than E14.5 were identified by PCR, and those of the older embryos and newborn individuals were determined by morphological criteria, as previously described (14).

Whole mount and section in situ hybridization
Embryos at given developmental stages were obtained by dissection of pregnant mice. The day when the plug was detected was designated d 0.5 of gestation. The tissues collected were fixed in 4% paraformaldehyde overnight, dehydrated in a graded methanol series, and stored in 100% methanol at -20 C for whole mount in situ hybridization. For section in situ hybridization, the fixed samples were dehydrated in an ethanol series, washed with xylene, and embedded in paraffin. Finally, the tissues were sectioned at 5 or 7 µm and placed on glass slides (Menzel-Glaser, Freiburgh, Germany) treated with triethoxysilylpropylamine (Sigma, St. Louis, MO).

The probes were Wnt-4 (14), Cyp21 and Cyp11B2 (Keith Parker, University of Texas Southwestern Medical Center, Dallas, TX), Hsd3b1 (Robin Lovell-Badge, National Institute for Medical Research, London, UK), Sf1 (18) and rat preadipocyte factor 1 (Pref-1; Hiroshi Takemori, Osaka University Medical School, Suita, Japan) cDNAs or parts of them, and the Cyp17-expressed sequence tag clone AA822113 (National Center for Biotechnology Information).

The riboprobes for whole mount in situ hybridization were labeled with digoxigenin (digoxigenin RNA labeling kit, Roche, Indianapolis, IN), and those for in situ sections were labeled with digoxigenin or [35S]UTP (Amersham Pharmacia Biotech, Arlington Heights, IL). The in situ hybridizations were performed according to standard procedures at 54 C for Pref-1 and at 65 C for the other probes (19), and hematoxylin eosin staining was performed as described by Hogan et al. (20). Both whole mount and in situ hybridization analyses were carried out for at least five independent samples in each case, and a representative one is shown here.

Morphometric studies
The adrenal glands were collected from E14.5 embryos and newborn mice and divided into four groups: wt females, wt males, Wnt-4 mutant females, and Wnt-4 mutant males. Two pairs of glands from each group were fixed overnight in 4% paraformaldehyde and dehydrated in an ascending series of ethanol solutions and xylenes, and the tissues were embedded in paraffin. Serial sections of 5 µm were cut, placed on microscope slides, and stained with toluidine blue. The total area of the adrenal gland was measured on each section with a digital image analysis system MCID-M4 (Imaging Research, Brock University, St. Catharines, Canada); the images were acquired with a Sony DXC-930P color video camera (Sony, Tokyo, Japan) attached to a Nikon Optiphot II microscope and a x4 objective (Nikon, Tokyo, Japan). Tissue volume was determined by integrating the section areas over their thicknesses. The volumes of the left and right adrenal glands of each animal were added together, and volume measurements were performed on two animals in each group.

Conventional and quantitative RT-PCR
The adrenal glands of the newborn mice were collected, quickly frozen in liquid nitrogen, and stored at -80 C. Later, 5–8 dissected adrenal glands were pooled by sex and phenotype (wt female, Wnt-4 mutant female, wt male, and Wnt-4 mutant male) for quantitative RT-PCR, and 10–20 pieces of gland for the conventional procedure. Total RNA was isolated with the Quick Prep kit from Amersham Pharmacia Biotech, and the reverse transcriptase reaction was carried out using the First Strand cDNA synthesis kit from MBI Fermentas (Hanover, NH) or Ready-To-Go RT-PCR Beads from Amersham Pharmacia Biotech. Cyp11B2 and Cyp21 mRNA concentrations in the samples were measured by quantitative RT PCR analysis as described (21). Conventional RT-PCR was carried out twice for Cyp17 using independent RNA samples and the expression of glyceraldehyde-3-phosphate dehydrogenase was used to assess the quality of the RNA. The forward and reverse primers and probes used are listed in Table 1Go.


View this table:
[in this window]
[in a new window]
 
Table 1. Forward and reverse primers and probes used in quantitative and conventional RT-PCR

 
Hormone analyses
Measurements were made of the concentrations of ß-endorphin, aldosterone, corticosterone, and cortisol in plasma samples and of testosterone, androstenedione, and dehydroepiandrosterone (DHEA) in adrenal gland tissue samples. Blood from decapitated mice was collected into heparinized glass tubes or Microvette CB 300 KE tubes (Sarstedt, Numbrecht, Germany) and centrifuged for 10 min at 3000 rpm, and the plasma samples were stored at -20 C. The plasma samples were pooled in a manner similar to that described above (four to six samples per tube to provide a sufficient volume). Adrenal tissues were collected from newborn mice, frozen quickly, and stored at -20 C. The tissues were sonicated for 15 sec in 100 µl distilled water and washed twice with 300 µl of a solution containing 9 vol diethyl ether and 1 vol ethyl acetate. After centrifugation, the water phase was taken for protein assays using a kit from Bio-Rad Laboratories, Inc. (Hercules, CA), and the organic phases were combined, evaporated, and assayed for steroids.

The evaporated organic phase was reconstituted with 500 µl RIA buffer (DRG Instruments GmbH, Marburg, Germany), and double aliquots of 25–100 µl were subjected to DHEA and androstenedione RIAs. Duplicate 5- to 25-µl aliquots of the plasma samples were submitted to the following RIAs: aldosterone (ICN Pharmaceuticals, Inc., Costa Mesa, CA), corticosterone (DRG Instruments GmbH), cortisol (Orion DG, Espoo, Finland), and ß-endorphin, also depicting the proportion of ACTH (ß-endorphin RIA) (22). The detection limits were 2 pg/ml for ßendorphin, 0.7 fmol/ml for dehydroepiandrosterone, 1 fmol/ml for androstenedione, 0.6 pmol/ml for aldosterone, 0.13 pmol/ml for corticosterone, 10 pg/ml for cortisol, and 1 µg/ml for total protein.

Statistical analyses
P values for the hormone and RT-PCR samples were calculated by t test with a two-tailed distribution and two-sample unequal variance.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Wnt-4 is expressed in the cortex of the developing mouse adrenal gland
The results of the whole mount hybridizations, performed to investigate the expression of Wnt-4 in the mouse embryo, revealed a circular area with Wnt-4 expression next to the anterior site of the mouse mesonephros on E11.5 (Fig. 1aGo), similar to the case of Sf1 expression (Fig. 1bGo), an early marker of the developing adrenal gland (23). By E12.5 the developing adrenal cortex was a distinct organ, and expression of Wnt-4 and Sf1 could clearly be seen in it (Fig. 1 1 , c and d). Section in situ hybridization of samples from E14.5 and E18.5 mice showed that the expression of Wnt-4 was located in the cortical region of the adrenal gland, whereas no expression could be detected in the medulla (Fig. 1Go, e and f). Wnt-4 expression in the developing adrenal gland was similar in both sexes (data not shown).



View larger version (97K):
[in this window]
[in a new window]
 
Figure 1. Whole mount and section in situ hybridization results for Wnt-4 expression in the adrenal gland. As early as E11.5 Wnt-4 is expressed in a small, circular area close to the anterior ends of the mesonephros (a, arrows), similar to Sf1 (b, arrow), marking the future adrenal gland. In b, the mesonephros is located beneath the gonad, which is also stained with the Sf1 probe. On E12.5 (c), Wnt-4 expression is localized in the developing adrenal gland, which also expresses Sf1 (d), and on E14.5 (e) and E18.5 (f), it is detected in the cortical region of the adrenal gland. Wnt-4 is also intensively expressed in the mesonephros and developing kidney. adr, Adrenal gland; g, gonad; k, kidney; m, mesonephros.

 
Adrenal glands of Wnt-4 mutant mice do not show distinct morphological alterations
The expression of Wnt-4 in the adrenal cortex of the mouse embryo throughout the development of the gland suggested that this factor plays a role in its development. Investigations into this using the Wnt-4 knockout mouse line (14) nevertheless failed to reveal any distinct morphological changes, such as deviant size or shape, in the adrenal glands of the Wnt-4 mutants (Fig. 2Go, a and b). Volume measurements, i.e. morphometric studies, performed on a few adrenal glands also suggested that the adrenal glands of the wt and Wnt-4 mutant mice were similar in size (data not shown), and hematoxylin-eosin staining did not reveal any obvious histologically anomalous structures in the Wnt-4 mutant adrenal glands (Fig. 2Go, c and d).



View larger version (155K):
[in this window]
[in a new window]
 
Figure 2. Hematoxylin-eosin staining shows no striking difference in morphology between the wt (a and c) and Wnt-4 mutant (b and d) adrenal glands at birth. -/-, Wnt-4 mutant; c, cortex; m, medulla.

 
Impaired steroid production in the adrenal cortex of Wnt-4 mutant mice
Expression of adrenal cortical layer markers and the steroidogenic genes Cyp21 and Cyp11B2 was analyzed in the adrenal glands of wt and Wnt-4 mutant newborn mice by section in situ hybridization and quantified by quantitative RT-PCR. The genes encode P450c21-hydroxylase (P450c21) and P450 aldosterone synthase (P450c11aldo), respectively, and their expression thus also depicts steroid production in the cortex. Cyp21 was intensively expressed in the glands of both wt and mutant Wnt-4 mice (Fig. 3Go, a and b), with no detectable quantitative difference (Table 2Go). In contrast, both in situ hybridization (Fig. 3Go, c and d) and the real-time PCR results (Table 2Go) showed the expression of Cyp11B2 to be reduced in the adrenal cortex of Wnt-4 mutant mice. As in Cyp11B2, the number of cells expressing Pref-1, which is a specific marker of the zona glomerulosa in the cortex (24), was markedly lower in the cortex of Wnt-4-deficient mice (Fig. 3Go, e and f). Pref-1 is also expressed in medullae (24), as seen here in the glands of both wt and Wnt-4 mutant mice. The male and female mice demonstrated similar expression patterns for these genes (data not shown).



View larger version (104K):
[in this window]
[in a new window]
 
Figure 3. Expression of Cyp21, Cyp11B2, and Pref-1 in the adrenal glands of newborn wt and Wnt-4 mutant (-/-) mice. Cyp21 is expressed throughout the cortical layers (dark purple) in both wt (a) and Wnt-4 mutant (b) adrenal glands. The strong expression also causes scattering of the signal around the organ. On the other hand, fewer cells expressing Cyp11B2 are seen in the Wnt-4 mutant adrenal gland (d) than in tissue from a wt mouse (c). Expression of Pref-1, a marker of the zona glomerulosa, occurs in a continuous ring around the adrenal glands of wt mice (e, arrows), whereas only a few cells express the factor in the glands of Wnt-4-deficient mice (f, arrows). Pref-1 is also abundant in the medulla of the adrenal gland in both wt and mutant mice. Several successive sections were hybridized to confirm that the results shown in the figures are not due to the location of the section surface.

 

View this table:
[in this window]
[in a new window]
 
Table 2. Cyp21 and Cyp11B2 mRNA levels in mouse adrenal gland measured by quantitative RT-PCR

 
Expression of the third steroidogenic gene, Cyp17, was first observed on E12.5 in the future adrenal glands of wt and Wnt-4 mutant male mice and of wt and mutant female mice (data not shown). In all of these cases expression peaked on E14.5, as judged by in situ hybridization (Fig. 4Go, a–d), and was most intensive in the cortex of the wt females (Fig. 4cGo). Thereafter it continued in the adrenal glands of the wt female animals until birth (Fig. 4gGo), but was lost between E16.5 and E18.5 in the glands of the wt and Wnt-4-deficient males and Wnt-4-deficient females (Fig. 4Go, e, f, and h). Thus, the expression of Cyp17 in the adrenal cortex of female Wnt-4 mutant mice followed that in wt male mice. RT-PCR confirmed the results of the whole mount in situ hybridization, showing Cyp17 expression to exist in the glands of newborn female wt mice, but not in those of Wnt-4-deficient mice, and to be more abundant on E14.5 than at birth (Fig. 4Go, i, j, and k). The expression was not seen in samples from adult wt mice (Fig. 4iGo).



View larger version (67K):
[in this window]
[in a new window]
 
Figure 4. Expression of Cyp17 in the developing urogenital systems of wt and Wnt-4-deficient mice. On E14.5 Cyp17 is weakly expressed in the adrenal glands of males (a and b) and Wnt-4 mutant females (d), but is considerably more intensive in those of wt females (c). On E18.5 strong expression is seen only in the glands of wt females (g, arrow), but not in other samples (e, f, and h, arrows). Cyp17 is also expressed in the gonads of males and Wnt-4 mutant females (arrowheads in d and h), but not in those of wt females (arrowheads in c and g). RT-PCR also shows Cyp17 expression in the adrenal glands of wt female mice, but not in those of Wnt-4-deficient mice, at birth, whereas it is abundant in both samples on E14.5 (i). Southern blotting and labeling with a Cyp17 probe have been used to intensify the lanes (i and j). In the control samples used only the lanes amplified with Cyp17 oligos from the testis sample are recognized (j), whereas ethidium bromide staining (k) demonstrates the quality of the RNA as tested with glyceraldehyde-3-phosphate dehydrogenase oligos and controls. C1 serves as a control for DNA contamination in the RNA sample, and C2 is a positive control for RT-PCR. ad, Adrenal gland; alt, adult; k, kidney; nb, newborn; o, ovary; st, DNA size marker; t, testis; 50, 50 ng RNA used; 300, 300 ng RNA used.

 
To investigate further the potential dysfunction of the adrenal cortex and pituitary-adrenal axis in Wnt-4-deficient mice, the plasma concentrations of aldosterone, ß-endorphin, corticosterone, and cortisol and the concentrations of DHEA, androstenedione, and testosterone in the adrenal gland tissue of newborn mice were measured. In agreement with the reduced Cyp11B2 expression, the production of aldosterone was significantly lower in Wnt-4 mutant mice, both male and female (Fig. 5aGo), whereas that of ß-endorphin (Fig. 5bGo), also reflecting ACTH production, was enhanced in these animals. In addition, a statistical difference in the production of corticosterone was seen between the wt and Wnt-4 mutant mice, both male and female (Fig. 5cGo). There was a high variation in corticosterone concentrations, which may be due to the effects of the circadian rhythm on corticosterone secretion. This rhythm could not be taken into account when collecting samples, because Wnt-4-deficient mice die soon after birth (14 16). The concentration of DHEA was constant in all the groups measured, and cortisol, androstenedione, and testosterone were below the detection level (data not shown), suggesting that Wnt-4 deficiency does not alter the main routes of steroidogenesis in the adrenal cortex, at least after birth.



View larger version (24K):
[in this window]
[in a new window]
 
Figure 5. Concentrations of aldosterone, ß-endorphin, and corticosterone measured in the plasma of wt and Wnt-4-deficient (-/-) newborn mice. a, The production of aldosterone is considerably decreased in the Wnt-4 mutant mice, both males and females (P < 0.0001; numbers of pools: wt males, n = 14; mutant males, n = 6; wt females, n = 13; mutant females, n = 5; each pool containing blood from six mice). b, ß-Endorphin is significantly elevated in both Wnt-4 mutant males (number of pools, n = 8; P < 0.001) and females (number of pools, n = 8; P < 0.01) relative to their wt littermates (number of pools: males, n = 7; females, n = 8). c, In addition, the elevation in corticosterone concentration is significant in the mutant females (number of pools, n = 12; P < 0.05; each pool containing blood from between four and six mice) when set against the wt mice (number of pools, n = 23), as is also the case in the male mice (number of pools: wt, n = 24; mutant, n = 12; P < 0.05). Comparison of all values for wt mice (females and males) with those for Wnt-4 mutant mice resulted in a significant difference (P < 0.001).

 
Migration and/or sorting of adrenal and gonadal cells may be disturbed in Wnt-4-deficient mice
The development of the adrenal cortex in wt and Wnt-4 mutant embryos from E11.5 to E13.5 was studied by monitoring the expression of Cyp21 (Fig. 6Go, a–f). Expression took place in a clear, circular area in the developing adrenal glands from wt mice (Fig. 6Go, a, c, and e), whereas in the Wnt-4 mutant mice, cells expressing Cyp21 were also dispersed outside the future adrenal cortex (Fig. 6Go, b, d, and f). Some Cyp21-positive cells were seen in the gonadal area (Fig. 6fGo), which does not normally express the gene (Fig. 6eGo), suggesting that the cells may be at least partially of adrenal origin. Expression patterns were similar in female and male mice (data not shown).



View larger version (114K):
[in this window]
[in a new window]
 
Figure 6. Expression of Cyp21 in the urogenital system of wt and Wnt-4 mutant (-/-) mice, as determined by whole mount in situ hybridization. Cyp21 is expressed only in the adrenal gland of wt embryos on E11.5 (a), E12.5 (c), and E13.5 (e). In the Wnt-4 mutant urogenital systems (b, d, and f), misplacement of the Cyp21-positive cells can also be seen in the gonadal region (arrows in b, d, and f). adr, Adrenal gland; d, duct; g, gonad.

 
Hsd3b1, the gene encoding 3ß-hydroxysteroid dehydrogenase type I (3ß-HSDI), was strongly expressed in the developing adrenal glands of both male and female mice on E14.5 (Fig. 7Go, a–d), and the expression was intensive in the gonads of wt (Fig. 7aGo) and Wnt-4-deficient (Fig. 7bGo) males and was detectable in the gonads of female Wnt-4-deficient mice (Fig. 7dGo), but not in female wt embryos (Fig. 7cGo). Ectopic expression of Hsd3b1 in the gonads of Wnt-4-deficient females was also distinct at birth (Fig. 7eGo) (16). Detailed examination showed that the 3ß-HSDI-positive cells were always located at the anterior end of the ovary, close to the adrenal, in the Wnt-4 mutant animals (Fig. 7dGo), as was also the case with Cyp21 (Fig. 6fGo). Similarly, Cyp17 was not expressed in the developing ovaries of normal mice, but extensive expression was seen in the anterior area of the Wnt-4 mutant ovary (Fig. 4Go, d and h).



View larger version (46K):
[in this window]
[in a new window]
 
Figure 7. Hsd3b1 is expressed intensively in the developing adrenal gland in both sexes (a–d), and is also expressed in the testis (a and b) and in the anterior tip of the gonad in Wnt-4 mutant females (d, arrow) on E14.5. Abundant ectopic expression of Hsd3b1 is also seen in the gonads of newborn Wnt-4 mutant females (e). Hsd3b1 is not expressed in the wt ovary (c, arrow). adr, Adrenal gland; k, kidney; nb, newborn; o, ovary; t, testis.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Wnt signaling factors regulate the development of a number of tissues, and the present findings demonstrate the involvement of Wnt-4 in the development of the adrenal cortex. On E11.5, Wnt-4 is expressed adjacent to the anterior site of the mouse mesonephros, correlating with formation of the anlage of the adrenal cortex between the mesogastrium and the urogenital fold and its protrusion between the mesonephros and the aorta. Wnt-4 expression also correlates with that of Sf1, which takes place throughout the adrenal primordium on E11 (23). During further development of the adrenal gland, Wnt-4 expression becomes established in its outermost cortical region, overlapping with that of Cyp11B2 and Pref-1. Expression of Wnt-11 has also been detected in the human adrenal cortex (25). The nuclear localization of ß-catenin in the glomerulosa cells of the human adrenal cortex (26) further indicates that the Wnt pathway is activated during development of mouse and human adrenal cortex.

Although the adrenal glands of wt and Wnt-4 mutant mice were similar in shape and size, it is possible that the elevated ß-endorphin concentration in the plasma of the Wnt-4-deficient animals, also reflecting the ACTH concentration, may lead to hyperplasia and/or hypertrophy, as is the case in Cushing-like syndrome (27), overexpression of CRH (28), and glucocorticoid receptor-deficient mice (29), even though the increase in corticosterone is more conspicuous in the later cases. As Wnt-4 mutant mice die soon after birth, it is unfortunately not possible to see how the production of corticosterone and ACTH and their effects are balanced out or whether the phenotype later shows adrenal hyperplasia or hypertrophy.

Hsd3b1, Cyp21, and Cyp11B2, which are needed for mineralocorticoid biosynthesis are expressed in the adrenal cortex of Wnt-4 mutants, although that of Cyp11B2 is significantly reduced, resulting in decreased production of aldosterone, the most important mineralocorticoid, which is exclusively synthesized in the zona glomerulosa (30). The principal functions of aldosterone are to stimulate sodium reabsorption in the distal tubule of the kidneys, to increase the total body sodium level, and to control the plasma potassium level. Lack of aldosterone causes reduced fluid volume, leading to hypovolemic shock and death. Hence Wnt-4 affects control of the electrolyte balance on at least two levels, being necessary for tubule formation in the kidney (14) and for maintaining a proper concentration of aldosterone.

The present section in situ hybridization results demonstrated that expression of Cyp11B2, the gene encoding P450c11aldo, and Pref-1, another marker of zona glomerulosa, is limited to a small number of cells, suggesting that the zona glomerulosa has not developed normally in the adrenal glands of Wnt-4 mutants. P450c11aldo is needed for the 11ß-hydroxylation of deoxycorticosterone to corticosterone and for the 18-hydroxylation and 18-hydroxydehydrogenation of corticosterone to aldosterone. The corticosterone concentrations in the mutant Wnt-4 mice suggest that the reduced amount of P450c11aldo does not significantly limit corticosterone biosynthesis, but instead affects the subsequent reactions on the path toward aldosterone, resulting in an accumulation or maintenance of corticosterone and a reduction in aldosterone. The situation is parallel, even though not equal, to that prevailing in human congenital hypoaldosteronism, in which corticosterone levels are increased and aldosterone levels decreased due to specific mutations in P450c11aldo affecting its 18-hydroxylation or 18-hydroxydehydrogenation activities (31, 32).

P450c17 catalyzes the 17{alpha}-hydroxylase and 17,20-lyase reactions and is thus necessary for the biosynthesis of cortisol and androgens. Adult mice and rats do not express Cyp17, and therefore their main glucocorticoid is corticosterone and not cortisol as in humans (33, 34, 35). Cyp17 expression does take place in the adrenal gland of the wt fetal mouse, however, reaching its peak on E14.5, and showing sex dependency. A pattern of Cyp17 expression similar to that demonstrated here in the male fetal adrenal gland has also been reported by Keeney et al. (36), but their material was not analyzed by sex, and expression in female fetuses at birth was not reported separately. Interestingly, we saw continued expression only in the adrenal cortex of wt females, whereas the pattern in Wnt-4-deficient females followed that in wt males. The results suggest that Wnt-4 is also involved in the regulation of steroidogenesis, with Wnt-4-deficient female embryos phenocopying the male pathway. Activation of the genes for the androgen biosynthesis pathway in the ovaries, masculinization of the gonads, and partial female to male sex reversal are also typical of mutant Wnt-4 female mice (16). The role of strong Cyp17 expression in the female adrenal gland remains open, as it was not found to affect cortisol or androgen production in the gland, at least at birth.

Expression of Cyp21 in the urogenital area is more dispersed in Wnt-4 mutant mice than in wt mice during embryological development. Some cells expressing Cyp21 are also seen in the gonadal area in Wnt-4-deficient male and female mice, an area not normally expressing the gene, and ectopic expression of the steroidogenic enzymes 3ß-HSDI and P450c17 also occurs in the gonads of female Wnt-4-deficient mice, leading to activation of the androgen biosynthesis pathway (16). Closer investigation of Wnt-4 mutant ovaries demonstrated that this ectopic expression always takes place at the anterior end of the gonad. The results suggest that the cells showing such expression are also of adrenal origin, and that Wnt-4 plays a role in cell sorting. The adrenal cortex and the gonadal cells have the same origin (37), and the gonad and future adrenal gland are located immediately adjacent to each other early in their development, on E11, without any clear border. A lack of Wnt-4 at that stage may thus allow some adrenal cells to migrate into the gonadal region, where they are able to maintain their original identity, still expressing Cyp17 and Hsd3b1.

The results show that Wnt signaling plays a role in the development of the adrenal cortex. The zona glomerulosa does not develop properly in Wnt-4-deficient mice, which leads to a decrease in the production of aldosterone. In addition, Wnt-4 may be involved in the regulation of steroidogenesis or at least in the expression of Cyp17, and finally, Wnt-4 may shape cell sorting between the adrenal cortex and the gonads.


    Acknowledgments
 
We thank Johanna Kekolahti-Liias, Hannele Härkman, Sanna Kalmukoski, and Soili Miettunen for their excellent technical assistance, and Terttu Keskitalo and Irja Leinonen for taking care of the Wnt-4 mice. We also thank Dr. Ahmed Yagi for helping to analyze the histological data.


    Footnotes
 
This work was supported by Academy of Finland (Grants 41001 and 46146), the Sigrid Juselius Foundation, and the European Union (Project QLRT-2000-01275). Some of the results were presented as a poster at the International Workshop on Developmental Endocrinology organized by the Ares-Serono Foundation, September 21–22, 2000, Cambridge, UK, and at the Keystone Symposia on Wnt and ß-Catenin signaling in Development and Disease, Taos, NM, March 5–10, 2002.

1 M.H. and H.P. have made equal contributions to this work. Back

Abbreviations: DHEA, Dehydroepiandrosterone; E, embryonic day; 3ß-HSDI, ß-hydroxysteroid dehydrogenase type I; Pref-1, preadipocyte factor 1; Sf1, steroidogenic factor-1; wt, wild-type.

Received March 6, 2002.

Accepted for publication July 19, 2002.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Nyska A, Maronpot R 1999 Adrenal gland. In: Maronpot R, Boorman G, Gaul B, eds. Pathology of the mouse. Reference and atlas. 1st ed. Vienna, IL: Cache River Press; 509–536
  2. Deacon CF, Mosley W, Jones IC 1986 The X zone of the mouse adrenal cortex of the Swiss albino strain. Gen Comp Endocrinol 61:87–99[CrossRef][Medline]
  3. Ehrhart-Bornstein M, Hinson JP, Bornstein SR, Scherbaum WA, Vinson GP 1998 Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev 19:101–143[Abstract/Free Full Text]
  4. Sass B 1996 Embryology, adrenal gland, mouse. In: Jones TC CC, Mohr U, eds. Endocrine system. Berlin, Heidelberg, New York: Springer-Verlag; 381–386
  5. Luo X, Ikeda Y, Parker KL 1994 A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77:481–490[CrossRef][Medline]
  6. Hatano O, Takayama K, Imai T, Waterman MR, Takakusu A, Omura T, Morohashi K 1994 Sex-dependent expression of a transcription factor, Ad4BP, regulating steroidogenic P-450 genes in the gonads during prenatal and postnatal rat development. Development 120:2787–2797[Abstract]
  7. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R 1993 WT-1 is required for early kidney development. Cell 74:679–691[CrossRef][Medline]
  8. Bose HS, Pescovitz OH, Miller WL 1997 Spontaneous feminization in a 46,XX female patient with congenital lipoid adrenal hyperplasia due to a homozygous frameshift mutation in the steroidogenic acute regulatory protein. J Clin Endocrinol Metab 82:1511–1515[Abstract/Free Full Text]
  9. Caron KM, Soo SC, Wetsel WC, Stocco DM, Clark BJ, Parker KL 1997 Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia. Proc Natl Acad Sci USA 94:11540–11545[Abstract/Free Full Text]
  10. Willert K, Nusse R 1998 ß-Catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev 8:95–102[CrossRef][Medline]
  11. Tada M, Smith JC 2000 Xwnt11 is a target of Xenopus brachyury: regulation of gastrulation movements via dishevelled, but not through the canonical Wnt pathway. Development 127:2227–2238[Abstract]
  12. Wallingford JB, Rowning BA, Vogeli KM, Rothbacher U, Fraser SE, Harland RM 2000 Dishevelled controls cell polarity during Xenopus gastrulation. Nature 405:81–85[CrossRef][Medline]
  13. Winklbauer R, Medina A, Swain RK, Steinbeisser H 2001 Frizzled-7 signalling controls tissue separation during Xenopus gastrulation. Nature 413:856–860[CrossRef][Medline]
  14. Stark K, Vainio S, Vassileva G, McMahon AP 1994 Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372:679–683[CrossRef][Medline]
  15. Treier M, Gleiberman AS, O’Connell SM, Szeto DP, McMahon JA, McMahon AP, Rosenfeld MG 1998 Multistep signaling requirements for pituitary organogenesis in vivo. Genes Dev 12:1691–1704[Abstract/Free Full Text]
  16. Vainio S, Heikkilä M, Kispert A, Chin N, McMahon AP 1999 Female development in mammals is regulated by Wnt-4 signalling. Nature 397:405–409[CrossRef][Medline]
  17. Brisken C, Heineman A, Chavarria T, Elenbaas B, Tan J, Dey SK, McMahon JA, McMahon AP, Weinberg RA 2000 Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev 14:650–654[Abstract/Free Full Text]
  18. Shen WH, Moore CC, Ikeda Y, Parker KL, Ingraham HA 1994 Nuclear receptor steroidogenic factor 1 regulates the mullerian inhibiting substance gene: a link to the sex determination cascade. Cell 77:651–661[CrossRef][Medline]
  19. Wilkinson D 1992 In situ hybridization: a practical approach. Oxford, New York, Tokyo: Oxford University Press
  20. Hogan B, Beddington R, Constantini F, Lacy E 1994 Manipulating the mouse embryo: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Press; 369–372
  21. Majalahti-Palviainen T, Hirvinen M, Tervonen V, Ilves M, Ruskoaho H, Vuolteenaho O 2000 Gene structure of a new cardiac peptide hormone: a model for heart-specific gene expression. Endocrinology 141:731–740[Abstract/Free Full Text]
  22. Vuolteenaho O, Leppaluoto J, Vakkuri O, Karppinen J, Hoyhtya M, Ling N 1981 Development and validation of a radioimmunoassay for ß-endorphin-related peptides. Acta Physiol Scand 112:313–321[Medline]
  23. Ikeda Y, Shen WH, Ingraham HA, Parker KL 1994 Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Mol Endocrinol 8:654–662[Abstract]
  24. Halder SK, Takemori H, Hatano O, Nonaka Y, Wada A, Okamoto M 1998 Cloning of a membrane-spanning protein with epidermal growth factor-like repeat motifs from adrenal glomerulosa cells. Endocrinology 139:3316–3328[Abstract/Free Full Text]
  25. Lako M, Strachan T, Bullen P, Wilson DI, Robson SC, Lindsay S 1998 Isolation, characterisation and embryonic expression of WNT11, a gene which maps to 11q13.5 and has possible roles in the development of skeleton, kidney and lung. Gene 219:101–110[CrossRef][Medline]
  26. Eberhart CG, Argani P 2001 Wnt signaling in human development: ß-catenin nuclear translocation in fetal lung, kidney, placenta, capillaries, adrenal, and cartilage. Pediatr Dev Pathol 4:351–357[CrossRef][Medline]
  27. Helseth A, Siegal GP, Haug E, Bautch VL 1992 Transgenic mice that develop pituitary tumors. A model for Cushing’s disease. Am J Pathol 140:1071–1080[Abstract]
  28. Stenzel-Poore MP, Cameron VA, Vaughan J, Sawchenko PE, Vale W 1992 Development of Cushing’s syndrome in corticotropin-releasing factor transgenic mice. Endocrinology 130:3378–3386[Abstract]
  29. Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, Fantuzzi G, Hummler E, Unsicker K, Schutz G 1995 Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 9:1608–1621[Abstract/Free Full Text]
  30. Ishimura K, Fujita H 1997 Light and electron microscopic immunohistochemistry of the localization of adrenal steroidogenic enzymes. Microsc Res Technol 36:445–453[CrossRef][Medline]
  31. Shizuta Y, Kawamoto T, Mitsuuchi Y, Miyahara K, Rosler A, Ulick S, Imura H 1995 Inborn errors of aldosterone biosynthesis in humans. Steroids 60:15–21[CrossRef][Medline]
  32. Peter M, Nikischin W, Heinz-Erian P, Fussenegger W, Kapelari K, Sippell WG 1998 Homozygous deletion of arginine-173 in the CYP11B2 gene in a girl with congenital hypoaldosteronism. Corticosterone methyloxydase deficiency type II. Horm Res 50:222–225[CrossRef][Medline]
  33. Voutilainen R, Tapanainen J, Chung BC, Matteson KJ, Miller WL 1986 Hormonal regulation of P450scc (20,22-desmolase) and P450c17 (17{alpha}-hydroxylase/17,20-lyase) in cultured human granulosa cells. J Clin Endocrinol Metab 63:202–207[Abstract]
  34. Perkins LM, Payne AH 1988 Quantification of P450scc, P450(17){alpha}, and iron sulfur protein reductase in Leydig cells and adrenals of inbred strains of mice. Endocrinology 123:2675–2682[Abstract]
  35. Brock BJ, Waterman MR 1999 Biochemical differences between rat and human cytochrome P450c17 support the different steroidogenic needs of these two species. Biochemistry 38:1598–1606[CrossRef][Medline]
  36. Keeney DS, Jenkins CM, Waterman MR 1995 Developmentally regulated expression of adrenal 17{alpha}-hydroxylase cytochrome P450 in the mouse embryo. Endocrinology 136:4872–4879[Abstract]
  37. Hatano O, Takakusu A, Nomura M, Morohashi K 1996 Identical origin of adrenal cortex and gonad revealed by expression profiles of Ad4BP/SF-1. Genes Cells 1:663–671[Abstract]



This article has been cited by other articles:


Home page
DevelopmentHome page
A. C. Kim, A. L. Reuter, M. Zubair, T. Else, K. Serecky, N. C. Bingham, G. G. Lavery, K. L. Parker, and G. D. Hammer
Targeted disruption of {beta}-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex
Development, August 1, 2008; 135(15): 2593 - 2602.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
C. H Brennan, A. Chittka, S. Barker, and G. P Vinson
Eph receptors and zonation in the rat adrenal cortex
J. Endocrinol., July 1, 2008; 198(1): 185 - 191.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
H. Chang, F. Gao, F. Guillou, M. M. Taketo, V. Huff, and R. R. Behringer
Wt1 negatively regulates {beta}-catenin signaling during testis development
Development, May 15, 2008; 135(10): 1875 - 1885.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
K. Tomizuka, K. Horikoshi, R. Kitada, Y. Sugawara, Y. Iba, A. Kojima, A. Yoshitome, K. Yamawaki, M. Amagai, A. Inoue, et al.
R-spondin1 plays an essential role in ovarian development through positively regulating Wnt-4 signaling
Hum. Mol. Genet., May 1, 2008; 17(9): 1278 - 1291.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
L. Hu, A. Monteiro, H. Johnston, P. King, and P. J O'Shaughnessy
Expression of Cyp21a1 and Cyp11b1 in the fetal mouse testis
Reproduction, October 1, 2007; 134(4): 585 - 591.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Q. Yang, R. Kurotani, A. Yamada, S. Kimura, and F. J. Gonzalez
Peroxisome Proliferator-Activated Receptor {alpha} Activation during Pregnancy Severely Impairs Mammary Lobuloalveolar Development in Mice
Endocrinology, October 1, 2006; 147(10): 4772 - 4780.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Chi, P. Itaranta, S. Zhang, and S. Vainio
Sprouty2 Is Involved in Male Sex Organogenesis by Controlling Fibroblast Growth Factor 9-Induced Mesonephric Cell Migration to the Developing Testis
Endocrinology, August 1, 2006; 147(8): 3777 - 3788.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
H. H.-C. Yao, J. Aardema, and K. Holthusen
Sexually Dimorphic Regulation of Inhibin Beta B in Establishing Gonadal Vasculature in Mice
Biol Reprod, May 1, 2006; 74(5): 978 - 983.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
M. Bielinska, S. Kiiveri, H. Parviainen, S. Mannisto, M. Heikinheimo, and D. B. Wilson
Gonadectomy-induced Adrenocortical Neoplasia in the Domestic Ferret (Mustela putorius furo) and Laboratory Mouse.
Vet. Pathol., February 1, 2006; 43(2): 97 - 117.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Heikkila, R. Prunskaite, F. Naillat, P. Itaranta, J. Vuoristo, J. Leppaluoto, H. Peltoketo, and S. Vainio
The Partial Female to Male Sex Reversal in Wnt-4-Deficient Females Involves Induced Expression of Testosterone Biosynthetic Genes and Testosterone Production, and Depends on Androgen Action
Endocrinology, September 1, 2005; 146(9): 4016 - 4023.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Y. Park and J. L. Jameson
Minireview: Transcriptional Regulation of Gonadal Development and Differentiation
Endocrinology, March 1, 2005; 146(3): 1035 - 1042.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. D. Hammer, K. L. Parker, and B. P. Schimmer
Minireview: Transcriptional Regulation of Adrenocortical Development
Endocrinology, March 1, 2005; 146(3): 1018 - 1024.
[Abstract] [Full Text] [PDF]


Home page
Sci Aging Knowl EnvironHome page
P. J. Hornsby
Aging of the Human Adrenal Cortex
Sci. Aging Knowl. Environ., September 1, 2004; 2004(35): re6 - re6.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
S. Cui, A. Ross, N. Stallings, K. L. Parker, B. Capel, and S. E. Quaggin
Disrupted gonadogenesis and male-to-female sex reversal in Pod1 knockout mice
Development, August 15, 2004; 131(16): 4095 - 4105.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. K. Jordan, J. H.-C. Shen, R. Olaso, H. A. Ingraham, and E. Vilain
Wnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1/{beta}-catenin synergy
PNAS, September 16, 2003; 100(19): 10866 - 10871.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
K. Jeays-Ward, C. Hoyle, J. Brennan, M. Dandonneau, G. Alldus, B. Capel, and A. Swain
Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad
Development, August 15, 2003; 130(16): 3663 - 3670.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. M. Gummow, J. N. Winnay, and G. D. Hammer
Convergence of Wnt Signaling and Steroidogenic Factor-1 (SF-1) on Transcription of the Rat Inhibin {alpha} Gene
J. Biol. Chem., July 11, 2003; 278(29): 26572 - 26579.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
J. Brennan, C. Tilmann, and B. Capel
Pdgfr-alpha mediates testis cord organization and fetal Leydig cell development in the XY gonad
Genes & Dev., March 15, 2003; 17(6): 800 - 810.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart